Type 2 diabetes is the world’s most prevalent chronic disease and often described as the silent killer. There are many drugs available for the disease yet patients are not able to maintain healthy levels of blood glucose.
The award was in recognition of their work on designing 3D bio-printed human models of Covid-19 and type 2 Diabetes which the company used to launch therapeutics in less than two years.
Hyderabad: ReaGene Innovations Pvt Ltd, a start-up incubated at the University of Hyderabad’s Incubation centre, ASPIRE BioNEST, has developed two saliva based diagnostic tests – ELISA and Fast Flow Spot- to detect neutralising activity of samples in response to Covid-19 vaccination. These diagnostics were licensed to Lay Science Inc, USA. After a vaccine against SarsCov2 […]
